InsidersTradesSigma
Q-linea AB: directors' dealings · Finland · FIN-FSA
FI:q-linea-ab-dccd56SE0011527845FI·FIN-FSAMcap 301M€Healthcare
Explore the full insider trade history of Q-linea AB, a publicly traded company based in Finland. Shares trade on FI FI, under the oversight of FIN-FSA. Operating in the Healthcare sector, Q-linea AB has recorded 6 insider filings. Market capitalisation: €301.3m. The latest transaction was reported on 11 November 2025 — Purchase. Among the most active insiders: Erika Kjellberg Eriksson. All data is free.
6
Insider Decl.
0
Thresholds
€4m
5 ops.
Buy Volume
€1,195
1 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
15.90 €
Analyst consensus
Income statement
Revenue11.1 M€
Gross profit−1.7 M€-15% margin
Net income−182.5 M€-1644.3% margin
Valuation
P/Book1.0x
Balance sheet & cash
Market cap301.3 M€
Total debt5.8 M€
Free Cash Flow−169.7 M€
Debt / Equity1%
Profitability & ownership
ROE-80.5%
ROA-39.4%
% insiders14.0%
% institutions25.4%
Last declaration on 11 November 2025
Declarations6 total
Executives●Purchase21FIN-FSA
€44,76119,740 shares@ €2.26750.015% mcap39.4% of flow
BTA (betald tecknad aktie)
FI:A003T503-1·
Ideal exit: 7 Aug 2026 (T+270)
Executives●Purchase20FIN-FSA
€95,23742,000 shares@ €2.26750.032% mcap100.0% of flow
BTA (betald tecknad aktie)
FI:A003T493-1·
Ideal exit: 7 Aug 2026 (T+270)
Executives●Purchase24FIN-FSA
€68,92930,398 shares@ €2.26750.023% mcap60.6% of flow
BTA (betald tecknad aktie)
FI:A003T496-1·
Ideal exit: 7 Aug 2026 (T+270)
Executives●Sale8FIN-FSA
€1,19585,260 shares@ €0.0140.0004% mcap0.0% of flow
Teckningsrätt/Uniträtt
FI:A003T248-1·
Executives●Purchase28FIN-FSA
€4m1,620,000 shares@ €2.28871.23% mcap100.0% of flow
BTA (betald tecknad aktie)
FI:A003T161-1·
Ideal exit: 24 Jul 2026 (T+270)
Executives●Purchase16FIN-FSA
€17542,240 shares@ €0.00410.0001% mcap100.0% of flow
Aktie
FI:A003M959-1·
Ideal exit: 22 Dec 2025 (T+270)
6 of 6 declarations